3MO First-line camrelizumab plus carboplatin and paclitaxel for advanced squamous non-small cell lung cancer: Updated overall survival results from the phase III CameL-sq trial
Titel:
3MO First-line camrelizumab plus carboplatin and paclitaxel for advanced squamous non-small cell lung cancer: Updated overall survival results from the phase III CameL-sq trial
Auteur:
Zhou, C. Cheng, Y. Chen, J. Xu, X. Chen, G. Pan, Y. Fang, Y. Wang, Q. Huang, Y. Yao, W. Wang, R. Li, X. Zhang, W. Zhang, Y. Shi, J. Cao, P. Wang, D. Lv, D. Luo, H. Yang, Z.